🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › Missouri › St. Louis

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa St. Louis, MO

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa St. Louis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Nagre-recruitPhase 3
  • Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton · 15 mi ang layo
  • Cancer Care Specialists of Illinois ( Site 0152), O'Fallon · 16 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06717347

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Nagre-recruitPhase 2
  • Cancer Care Specialists of Central Illinois, Swansea · 13 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06806033

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Nagre-recruitPhase 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • at 2 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06649812

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Nagre-recruitPhase 2
  • Washington University School of Medicine - Siteman Cancer Center, St Louis
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06500273

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Nagre-recruitPhase 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • at 2 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05890352

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Nagre-recruitPhase 2
  • Washington University School of Medicine, St Louis
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06687772

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2
  • Washington University, St. Louis, St Louis
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Nagre-recruitPhase 2
  • Siteman Cancer Center at Washington University, St Louis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 26, 2024 · NCT06238648

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa St. Louis

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.